These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

615 related items for PubMed ID: 20434117

  • 1. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J, Medina M, Racedo S, Alvarez S.
    J Microbiol Immunol Infect; 2010 Feb; 43(1):1-10. PubMed ID: 20434117
    [Abstract] [Full Text] [Related]

  • 2. Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection.
    Villena J, Medina M, Raya R, Alvarez S.
    Can J Microbiol; 2008 Oct; 54(10):845-53. PubMed ID: 18923553
    [Abstract] [Full Text] [Related]

  • 3. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection.
    Hanniffy SB, Carter AT, Hitchin E, Wells JM.
    J Infect Dis; 2007 Jan 15; 195(2):185-93. PubMed ID: 17191163
    [Abstract] [Full Text] [Related]

  • 4. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B.
    Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I.
    J Infect Dis; 2001 Jan 15; 183(2):253-260. PubMed ID: 11110649
    [Abstract] [Full Text] [Related]

  • 5. Stimulation of respiratory immunity by oral administration of Lactococcus lactis.
    Villena J, Medina M, Vintiñi E, Alvarez S.
    Can J Microbiol; 2008 Aug 15; 54(8):630-8. PubMed ID: 18772925
    [Abstract] [Full Text] [Related]

  • 6. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 15; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 7. Nasal administration of Lactococcus lactis improves local and systemic immune responses against Streptococcus pneumoniae.
    Medina M, Villena J, Salva S, Vintiñi E, Langella P, Alvarez S.
    Microbiol Immunol; 2008 Aug 15; 52(8):399-409. PubMed ID: 18667039
    [Abstract] [Full Text] [Related]

  • 8. Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.
    Nguyen CT, Kim SY, Kim MS, Lee SE, Rhee JH.
    Vaccine; 2011 Aug 05; 29(34):5731-9. PubMed ID: 21696869
    [Abstract] [Full Text] [Related]

  • 9. Compound 48/80 acts as a potent mucosal adjuvant for vaccination against Streptococcus pneumoniae infection in young mice.
    Zeng L, Liu Y, Wang H, Liao P, Song Z, Gao S, Wu Y, Zhang X, Yin Y, Xu W.
    Vaccine; 2015 Feb 18; 33(8):1008-16. PubMed ID: 25595867
    [Abstract] [Full Text] [Related]

  • 10. Lactococcus lactis GEM particles displaying pneumococcal antigens induce local and systemic immune responses following intranasal immunization.
    Audouy SA, van Roosmalen ML, Neef J, Kanninga R, Post E, van Deemter M, Metselaar H, van Selm S, Robillard GT, Leenhouts KJ, Hermans PW.
    Vaccine; 2006 Jun 29; 24(26):5434-41. PubMed ID: 16757068
    [Abstract] [Full Text] [Related]

  • 11. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
    Sabirov A, Metzger DW.
    Vaccine; 2006 Jul 07; 24(27-28):5584-92. PubMed ID: 16730398
    [Abstract] [Full Text] [Related]

  • 12. Nasal immunization with Lactococcus lactis expressing the pneumococcal protective protein A induces protective immunity in mice.
    Medina M, Villena J, Vintiñi E, Hebert EM, Raya R, Alvarez S.
    Infect Immun; 2008 Jun 07; 76(6):2696-705. PubMed ID: 18390997
    [Abstract] [Full Text] [Related]

  • 13. Th17/Th1 biased immunity to the pneumococcal proteins PcsB, StkP and PsaA in adults of different age.
    Schmid P, Selak S, Keller M, Luhan B, Magyarics Z, Seidel S, Schlick P, Reinisch C, Lingnau K, Nagy E, Grubeck-Loebenstein B.
    Vaccine; 2011 May 23; 29(23):3982-9. PubMed ID: 21481328
    [Abstract] [Full Text] [Related]

  • 14. Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae.
    Cui Y, Zhang X, Gong Y, Niu S, Yin N, Yao R, Xu W, Li D, Wang H, He Y, Cao J, Yin Y.
    Vaccine; 2011 Feb 17; 29(9):1736-44. PubMed ID: 21238570
    [Abstract] [Full Text] [Related]

  • 15. Mucosal immunization with polyamine transport protein D (PotD) protects mice against nasopharyngeal colonization with Streptococcus pneumoniae.
    Shah P, Briles DE, King J, Hale Y, Swiatlo E.
    Exp Biol Med (Maywood); 2009 Apr 17; 234(4):403-9. PubMed ID: 19176871
    [Abstract] [Full Text] [Related]

  • 16. Administration of a probiotic associated with nasal vaccination with inactivated Lactococcus lactis-PppA induces effective protection against pneumoccocal infection in young mice.
    Vintiñi E, Villena J, Alvarez S, Medina M.
    Clin Exp Immunol; 2010 Mar 17; 159(3):351-62. PubMed ID: 20002449
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine.
    Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène JP, Lommel P, Dieussaert I, Schuerman L.
    Pediatr Infect Dis J; 2009 Apr 17; 28(4 Suppl):S66-76. PubMed ID: 19325449
    [Abstract] [Full Text] [Related]

  • 18. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K, Yao R, Wang H, Pang D, Liu Y, Xu H, Zhang S, Zhang X, Yin Y.
    Vaccine; 2014 Jul 16; 32(33):4179-88. PubMed ID: 24945468
    [Abstract] [Full Text] [Related]

  • 19. Intranasal immunization with the cholera toxin B subunit-pneumococcal surface antigen A fusion protein induces protection against colonization with Streptococcus pneumoniae and has negligible impact on the nasopharyngeal and oral microbiota of mice.
    Pimenta FC, Miyaji EN, Arêas AP, Oliveira ML, de Andrade AL, Ho PL, Hollingshead SK, Leite LC.
    Infect Immun; 2006 Aug 16; 74(8):4939-44. PubMed ID: 16861686
    [Abstract] [Full Text] [Related]

  • 20. Enhanced protective immunity against pneumococcal infection with PspA DNA and protein.
    Moore QC, Bosarge JR, Quin LR, McDaniel LS.
    Vaccine; 2006 Jul 17; 24(29-30):5755-61. PubMed ID: 16759765
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.